Screener
Relay Therapeutics, Inc. RLAY Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s net income?
- Relay Therapeutics, Inc. (RLAY) reported net income of -$83.71M in Q2 2026.
- How has Relay Therapeutics, Inc.'s net income changed year-over-year?
- Relay Therapeutics, Inc.'s net income decreased by 18.9% year-over-year, from -$70.38M to -$83.71M.
- What is the long-term trend for Relay Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s net income has grown at a -6.6% compound annual growth rate (CAGR), from -$363.87M to -$276.48M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Relay Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude